Compare Nuwellis Inc (NUWE) vs PAGSEG Inc (PAGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs PAGSEG Inc — how do they compare? Nuwellis Inc trades at $1.48 (market cap $542.80K), while PAGSEG Inc trades at $8.85 (market cap $2.48B). The key difference: PAGSEG Inc is far larger — about 4568.9× Nuwellis Inc's market cap, and PAGSEG Inc pays a 11.7% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | PAGS | |
|---|---|---|
Market Cap | $542.80K | $2.48B |
Sector | Technology | Technology |
52-Week High | $220.50 | $12.00 |
52-Week Low | $1.42 | $8.38 |
Enterprise Value | -$1.27M | $10.22B |
Dividend Yield | — | 11.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
PAGS trades at $9.14, down 2.35% on the day, with a bearish technical signal from moving averages but oversold RSI conditions. The stock shows strong fundamentals with a P/E of 6.31, net income margin of 10.4%, and positive cash flow. Recent earnings have been mixed, with a miss in Q1 2026 but a beat in Q4 2025, while analyst sentiment remains largely positive.
The outlook for PAGS is cautiously optimistic, supported by deep value metrics and a consensus price target of $11.45, implying significant upside. Risks include competitive pressures in financial services and sensitivity to Brazilian interest rates, but robust profitability and aggressive capital returns provide a buffer against near-term volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About PAGSEG Inc
PagSeguro Digital Ltd. is a leading provider of financial technology solutions in Brazil, primarily focused on e-commerce, face-to-face transactions, and financial services. The company's main offerings include PagBank, a digital banking platform, and PagSeguro, a suite of payment processing solutions that includes point-of-sale devices and online payment gateways. PAGS targets micro-merchants, small and medium-sized enterprises (SMEs), and consumers, aiming to democratize access to financial services in the country.
Read more on PAGS →
